0 reads
Leave a comment


The U.S. Food and Drug Administration have approved GlaxoSmith Kline’s version of its H1N1 pandemic vaccine.More than 7 million doses of this vaccine will be delivered to the U.S. in December. The vaccine is the unadjuvanted vaccine for use in adults.

Also On The Light 103.9 FM:
Lamplighter Awards 2017! [PHOTOS]
Lamplighter Awards 2017
100 photos
comments – add yours